Taiwan-based vaccine maker #Medigen will conduct a Phase 3 clinical trial for its #COVID19 vaccine in Europe once it has received approval from European authorities, which would help pave the way for its entry into European and other international markets, the company announced Wednesday.
https://focustaiwan.tw/business/202109230012